🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We had such an amazing time and many fruitful discussions! Thank you Rizwan Romee for visiting us and sharing your exciting work in the #NK field with us! Looking forward to your lecture today! Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center

Excited to share our paper in collab with ⁦Ghobrial Lab⁩ led by ⁦Stahri⁩ ⁦Sara Piccinelli⁩ showing the role of MICA/B shedding causing immune escape in myeloma and its prevention by 7C6 mab. #NK ⁦Dana-Farber⁩ #romeelab ashpublications.org/bloodadvances/…

IL-21 engineering enhances NK cell activity against glioblastoma via CEBPD Cancer Cell cell.com/cancer-cell/fu… Nicholas Huntington cell.com/cancer-cell/fu… Katy Rezvani, M.D., Ph.D Mayra Shanley

Preclinical findings from research led by Dr. Katy Rezvani represent the first evidence that engineering NK cells to secrete IL-21 resulted in strong activity against glioblastoma. Read more: bit.ly/3AnoWwn Katy Rezvani, M.D., Ph.D #Glioblastoma #EndCancer

I am very excited about publishing our story of engineering NK cells with IL-21 for cellular therapy of glioblastoma. This was a labor of love and a huge team effort! Thank you Katy for all your mentorship and support! Glad to be part of your team 😊!

Congratulations to Mayra Shanley and Katy Rezvani, M.D., Ph.D team for this beautiful story just published in @Canc_Cell of IL-21 engineered NK cells for cell therapy of glioblastoma! Very excited about the clinical translation ahead! The future is bright for NK cell therapy ❤️🎊🎉!#NK #GBM

I am so proud of my friend and colleague Mayra Shanley for her amazing paper just out in Cancer Cell! All your hard work and dedication paid off Mayra 🥳 such an impactful work for the #NK cell field! Congratulations!! Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center #IL21 #cytokine #celltherapy

Congratulations Mayra Shanley. I am so proud of all that you’ve accomplished. So looking forward to seeing your efforts translated to the clinic. #NK #glioblastoma MD Anderson Cancer Center

Congrats! to my very dear friend Mayra Shanley and Katy Rezvani, M.D., Ph.D for this remarkable work. It has been fun sharing the office with you and witness this inspiring journey. Cheers to many more accomplishments.

Congratulations Mayra Shanley and Katy Rezvani, M.D., Ph.D on this groundbreaking study! I am really proud of you Mayra Shanley ,so well-deserved. Keep up amazing work,I cannot wait to see impact it will have on our patients. #NK #GBM

Engineering NK cells with IL-21 for cellular therapy of glioblastoma - Mayra Shanley Katy Rezvani, M.D., Ph.D May Daher Hind Rafei Merve Dede Dr. Elizabeth Shpall oncodaily.com/insight/124241 #Cancer #Glioblastoma #BrainCancer #CancerResearch #OncoDaily #Oncology

Oncoinfluencers to Follow on Social Media: Dr. Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center oncodaily.com/blog/126866 #Cancer #MedOnc #Oncologist #OncoDaily #Oncology

In cocultures of glioblastoma stem cells and in PDX mouse models of glioblastoma, Shanley et al. showed that arming NK cells with IL-21 was safe and induced long-term antitumor activity, while arming [...] bit.ly/4dPYUjQ  Mayra Shanley  Katy Rezvani, M.D., Ph.D

Congratulations May Daher Bijender Kumar Katy Rezvani, M.D., Ph.D and team for this beautiful story and all the translations that could come out of it for AML with NK and CAR NK cell therapy! 🎊🎉 MD Anderson Cancer Center #NK #AML

Congratulations, May Daher! So proud of you and can’t wait to see what the future holds for you. Cheers to this and many more to come!

Excited to share our new publication in Science Translational Medicine. Incredibly proud of my AML buddy May Daher for shaping this project. Thanks a ton to our amazing mentor Katy Rezvani, M.D., Ph.D for her never ending support and guidance that has been a pivotal part of my professional journey.

Heartfelt congratulations to my incredibly talented and exceptionally intelligent friend May Daher on her remarkable publication in Science Translational Medicine I’m beyond proud of your brilliance and dedication. Here’s to many more successes and groundbreaking contributions to come. Katy Rezvani, M.D., Ph.D

Congrats Katy Rezvani, M.D., Ph.D and May Daher on this amazing study! I feel so fortunate to have been part of this team and witness our journey from very beginning to now. Here’s to many more accomplishments ahead!

Our Dr. Katy Rezvani presented her latest research on CAR NK cells at #ESMO24. See the full schedule for tomorrow's presentations: brnw.ch/21wMGMs ESMO - Eur. Oncology Katy Rezvani, M.D., Ph.D #EndCancer

Outstanding presentation by my friend and colleague sunil acharya at CAR-TCR summit, highlighting cutting-edge preclinical and early clinical data on CD70 CAR NK cells. Remarkable work, Sunil—truly well done! Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center